If confined details exists involving scientific tests of allergenic cross-reactivity in opioid prescription drugs, the potential for cross-sensitivity cannot be thoroughly excluded. For sufferers using an opioid allergy, a clear description of the allergic response must be explored and documented sufficiently ahead of considering oxycodone.Art